Introduction
The β amyloid peptide (Aβ), which is likely to be centrally involved in Alzheimer's disease (AD) pathology (Hardy and Selkoe, 2002) , has an inherent capacity to multimerize and aggregate in vitro and in vivo (Finder and Glockshuber, 2007) . It is unknown if the capacity of the β amyloid peptide to multimerize rapidly and aggregate serves a selected function, or if this aggregation ability is an unselected consequence of some other selected capacity. Other larger proteins associated with neurodegenerative diseases, such as prion protein (PrP) and polyglutamine repeat-containing proteins (e.g., huntingtin) show similar aggregation capacities (Koo et al., 1999) . The aggregation of polyglutamine repeat proteins depends specifically on the repeat sequence; addition of long polyglutamine repeats to normally soluble proteins, such as Green Fluorescent Protein (GFP), causes aggressive aggregation of the fusion protein (Moulder et al., 1999; Satyal et al., 2000) . Similarly, molecular dissection of yeast prion proteins has demonstrated that a glutamine/asparagine-rich domain is responsible for their aggregation, and this domain can convey aggregation when fused to heterologous soluble proteins (DePace et al., 1998; Li and Lindquist, 2000; Osherovich and Weissman, 2001; Osherovich et al., 2004) . Si et al. identified a neuronal isoform of the Aplysia CPEB protein that contains a glutamine/asparagine-rich domain that can likewise convey prion-like properties when fused to heterologous proteins and expressed in yeast (Si et al., 2003) . These authors suggested that the conversion of CPEB to a prion-like state might be important for the function of this protein, as it could allow the establishment of a localized, stable epigenetic switch important for maintaining long-term synaptic changes.
The Aβ peptide is derived by proteolytic cleavage from the Amyloid Precursor Protein (APP), a broadly expressed protein with multiple functions, including a proposed role in synaptic function (Kamenetz et al., 2003) . By analogy with the glutamine/asparagine-rich domain of CPEB, the Aβ peptide sequence could function as an aggregation domain and play a role in the function of its "host" protein, APP. We therefore sought to determine 1) if the Aβ sequence could serve as a transferable aggregation domain module, and 2) if interference with the proposed aggregation capacity of the Aβ sequence could modulate APP function. We find that the Aβ sequence can act as an aggregation module, and that APP processing is altered by introduction of a mutation in the Aβ domain that abrogates its aggregation potential.
Methods

Construction of transgenes and transgenic strains
The human Aβ 3-42 sequence was cloned in frame downstream of GFP in C. elegans expression vectors that use either the myo-3 
